Leukotriene antagonists and symptom control in chronic persistent asthma

被引：12

作者：

Green, RH ^{[1
]}

Pavord, ID ^{[1
]}

机构：

[1] Glenfield Hosp, Dept Resp Med, Inst Lung Hlth, Leicester LE3 9QP, Leics, England

来源：

LANCET | 2001年 / 357卷 / 9273期

关键词：

D O I：

10.1016/S0140-6736(00)05132-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1991 / 1992

页数：2

共 19 条

[11] Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients [J].

Löfdahl, CG ;

Reiss, TF ;

Leff, JA ;

Israel, E ;

Noonan, MJ ;

Finn, AF ;

Seidenberg, BC ;

Capizzi, T ;

Kundu, S ;

Godard, P .

BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7202) :87-90

[12] INHIBITION OF EXERCISE-INDUCED BRONCHOCONSTRICTION BY MK-571, A POTENT LEUKOTRIENE-D4 RECEPTOR ANTAGONIST [J].

MANNING, PJ ;

WATSON, RM ;

MARGOLSKEE, DJ ;

WILLIAMS, VC ;

SCHWARTZ, JI ;

OBYRNE, PM .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1736-1739

[13] Effect of inhaled formoterol and budesonide on exacerbations of asthma [J].

Pauwels, RA ;

Lofdahl, CG ;

Postma, DS ;

Tattersfield, AE ;

OByrne, P ;

Barnes, PJ ;

Ullman, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (20) :1405-1411

[14] Induced sputum eicosanoid concentrations in asthma [J].

Pavord, ID ;

Ward, R ;

Woltmann, G ;

Wardlaw, AJ ;

Sheller, JR ;

Dworski, R .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (06) :1905-1909

[15] Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial [J].

Pizzichini, E ;

Leff, JA ;

Reiss, TF ;

Hendeles, L ;

Boulet, LP ;

Wei, LX ;

Efthimiadis, AE ;

Zhang, J ;

Hargreave, FE .

EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (01) :12-18

[16] Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids [J].

Reiss, TF ;

Sorkness, CA ;

Stricker, W ;

Botto, A ;

Busse, WW ;

Kundu, S ;

Zhang, J .

THORAX, 1997, 52 (01) :45-48

[17] Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast [J].

Sampson, AP ;

Siddiqui, S ;

Buchanan, D ;

Howarth, PH ;

Holgate, ST ;

Holloway, JW ;

Sayers, I .

THORAX, 2000, 55 :S28-S31

[18] EFFECTS OF 6 WEEKS OF THERAPY WITH ORAL DOSES OF ICI-204,219, A LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, IN SUBJECTS WITH BRONCHIAL-ASTHMA [J].

SPECTOR, SL ;

SMITH, LJ ;

GLASS, M ;

BIRMINGHAM, BK ;

BRONSKY, EA ;

DUNN, KD ;

FISH, JE ;

GROSSMAN, J ;

HOWLAND, W ;

MINKWITZ, MC ;

LARSEN, JS ;

NATHAN, RA ;

RENNARD, SI ;

SCHULMAN, ES ;

SEGAL, A ;

SELTZER, LM .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (03) :618-623

[19] EFFECT OF CYSTEINYL-LEUKOTRIENE RECEPTOR ANTAGONIST ICI 204.219 ON ALLERGEN-INDUCED BRONCHOCONSTRICTION AND AIRWAY HYPERREACTIVITY IN ATOPIC SUBJECTS [J].

TAYLOR, IK ;

OSHAUGHNESSY, KM ;

FULLER, RW ;

DOLLERY, CT .

LANCET, 1991, 337 (8743) :690-694

← 1 2 →